stocks logo

GOCO Earnings

Gohealth Inc
$
5.830
+0.06(1.040%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

Earning Analysis

Welcome to our in-depth analysis of Gohealth Inc(GOCO) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Gohealth Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
FY2025Q22025-08-07Pre-Market-2.60-1.23+52.69110.30M94.05M-14.73-9.19-7.61
FY2025Q12025-05-13Pre-Market-0.26-0.47-80.77221.61M220.97M-0.29-0.25-12.30
FY2024Q42025-02-27Pre-Market1.162.41+107.76326.56M389.13M+19.16-14.45-13.63
FY2024Q22024-08-08Pre-Market-2.47--141.79M105.87M-25.33-20.78-30.13
FY2024Q12024-05-09--0.84-0.89-5.95178.80M185.60M+3.80-3.78-9.60
FY2023Q42024-03-14-2.730.60-78.02363.88M276.70M-23.96-13.17-22.21
FY2023Q32023-11-09--2.90-2.61+10.00138.25M132.04M-4.49-0.84+12.06
FY2023Q22023-08-10--2.66-1.77+33.46115.62M142.78M+23.49+4.19+7.82
-2023-05-08--1.74-1.12+35.63---+32.24+44.76
-2023-03-16-2.557.00-374.51---+6.06-8.30

Get winning stock picks in minutes

GOCO Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Gohealth Inc reported performance for FY2025Q2, announced on 2025-08-07. The company achieved an EPS of -1.23, compared to analyst estimates of -2.60 by 52.69% . Revenue for the quarter reached 94.05M compared to expectations of 110.30M by -14.73% .
The stock price reacted with a -9.19% one-day change and a -7.61% five-day change following the earnings release. These movements reflect market reaction in Gohealth Inc growth trajectory and strategic initiatives.

GOCO Earnings Forecast

Looking ahead, Gohealth Inc(GOCO) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 103.75M and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -2.77%, while EPS estimates have been Revise Downward by -17.66%. For the upcoming , revenue estimates have been adjusted Go Down by -28.11% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Gohealth Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between GOCO's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.77%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Downward
down Image
-17.66%
In Past 3 Month
Stock Price
Go Down
down Image
-28.11%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
--
Revenue Estimate-Annual FY 2025:831.53M
--
EPS Estimate-Annual FY 2025:0
Stock Price5.83

Get winning stock picks in minutes

GOCO Revenue and EPS Performance: A Historical Perspective

Gohealth Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-07,Pre-Market):
EPS: -1.23 (Actual) vs.-2.60 (Estimate) (52.69%)
Revenue: 94.05M (Actual) vs. 110.30M (Estimate) (-14.73%)
Price Reaction: -9.19%(1-Day), -7.61%(5-Day)
FY2025Q1 (2025-05-13,Pre-Market):
EPS: -0.47 (Actual) vs.-0.26 (Estimate) (-80.77%)
Revenue: 220.97M (Actual) vs. 221.61M (Estimate) (-0.29%)
Price Reaction: -0.25%(1-Day), -12.30%(5-Day)
FY2024Q4 (2025-02-27,Pre-Market):
EPS: 2.41 (Actual) vs.1.16 (Estimate) (107.76%)
Revenue: 389.13M (Actual) vs. 326.56M (Estimate) (19.16%)
Price Reaction: -14.45%(1-Day), -13.63%(5-Day)
Earnings Reaction
The chart below shows how GOCO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GOCO sees a +11.61% change in stock price 10 days leading up to the earnings, and a -1.95% change 10 days following the report. On the earnings day itself, the stock moves by -2.00%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -2.44% on the day following the earnings release and then changed by 1.75% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

Transcript Summary

Gohealth Inc (GOCO) Q2 2025 Earnings Call Summary
Neutral
2025-08-08
The earnings call reveals a mixed picture: positive developments like GoHealth Protect's launch and strategic M&A plans are offset by financial concerns such as intangible asset impairment and share dilution. The Q&A session highlights management's focus on strategic growth and financial flexibility, yet it also exposes uncertainties in revenue and cost structures. Given these factors, the sentiment is neutral, as positive aspects are balanced by financial challenges and market uncertainties.
Gohealth Inc (GOCO) Q1 2025 Earnings Call Summary
Negative
2025-05-14
Despite strong revenue growth and improved EBITDA, the negative cash flow, legal issues, and lack of clear guidance on future revenue trends overshadow positives. The DOJ lawsuit and potential AEP disruptions raise significant concerns. The absence of a share repurchase plan and unclear management responses further contribute to a negative sentiment. Given these factors, the stock price is likely to experience a negative reaction in the near term.
Gohealth Inc (GOCO) Q1 2025 Earnings Call Summary
Neutral
2025-05-13
The earnings call presents mixed signals: strong revenue growth, improved EBITDA, and reduced customer acquisition costs are positive. However, the negative cash flow, legal risks from the DOJ lawsuit, and lack of clear guidance are concerning. The market dynamics and operational efficiency are favorable, but uncertainties around the AEP and DOJ intervention pose risks. The Q&A highlights management's cautious outlook and lack of specific guidance, which tempers optimism. Overall, the sentiment is neutral given the balance of positive financials and significant uncertainties.
Gohealth Inc (GOCO) Q4 2024 Earnings Call Summary
Positive
2025-02-27
The earnings call presented strong financial performance with significant revenue and EBITDA growth, improved operational efficiency, and reduced customer acquisition costs. Despite negative cash flow, the refinancing of the term loan facility provides financial stability. The Q&A highlighted effective strategies and market positioning, with management addressing potential risks and opportunities. The overall sentiment is positive due to strong earnings, optimistic guidance, and strategic initiatives, indicating a likely positive stock price movement.
GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Summary
Neutral
2024-11-09
The earnings call presents a mixed picture. The acquisition of e-TeleQuote and refinancing of the term loan are positive developments. However, the decline in net revenues and adjusted EBITDA, along with the significant impact of a cyber-attack, are concerning. The Q&A section reveals cautious optimism but lacks specific guidance, especially regarding debt targets. The anticipated decline in cash flow from operations also tempers enthusiasm. Overall, the sentiment is balanced by positive strategic moves and operational challenges, leading to a neutral stock price prediction.
GoHealth, Inc. (GOCO) Q2 2024 Earnings Call Summary
Negative
2024-08-08
The earnings call summary indicates negative financial performance with declining revenues, negative EBITDA, and cash flow issues. The Q&A reveals management's vague responses on refinancing and capital structure, raising concerns. Competitive pressures are somewhat mitigated by competitor exits, but supply chain challenges and economic factors like premium increases present risks. The absence of a share buyback program further dampens sentiment. Overall, despite some positive aspects like improved agent efficiency, the negative financial metrics and lack of clear guidance suggest a negative stock price movement.

FAQ

arrow icon

What were the key highlights of GOCO’s latest earnings report for FY2025Q2?

GOCO reported its FY2025Q2 earnings on 2025-08-07, showcasing a revenue of 94.05M against an estimate of 110.30M, resulting in a -14.73% surprise. The EPS was -1.23, surpassing the expected -2.6 by 52.69% . The stock experienced a -9.19% price change on the earnings day and a -7.61% change over the next five days, reflecting market reactions to the results.
arrow icon

How did GOCO’s stock price react after the FY2025Q2 earnings release?

arrow icon

What are the revenue and EPS estimates for GOCO for 2025/Q3?

arrow icon

How does GOCO’s stock price correlate with earnings forecast revisions?

arrow icon

What should investors expect from GOCO’s next earnings report?

arrow icon

What is the sentiment in Gohealth Inc (GOCO) Q2 2025 Earnings Call Summary?